Opportunity Information: Apply for PA 15 141
Apply for PA 15 141
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "International Research Collaboration on Drug Abuse and Addiction Research (R03)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Mar 17, 2015 and posted on Mar 17, 2015.
- Applicants must submit their applications by May 7, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) For profit organizations other than small businesses Others (see text field entitled Additional Information on Eligibility for clarification) County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses City or township governments Special district governments Independent school districts.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The International Research Collaboration on Drug Abuse and Addiction Research (R03) funding opportunity (PA 15-141) is a National Institutes of Health grant announcement that invites short, focused research projects in drug abuse and addiction that rely on partnerships and advantages found outside the United States. The central idea is to support collaborative studies that can move the science forward faster because they can tap into resources that are difficult or impossible to access domestically, such as unique expertise, specialized facilities, distinctive datasets, particular environmental conditions, or specific populations and settings in other countries. Applications are expected to align with the mission of the National Institute on Drug Abuse (NIDA) and, when practical, to connect with NIDA international scientific priority areas, recognizing that these priorities may shift over time.
In practical terms, the opportunity is designed for the NIH R03 mechanism, which is meant for discrete, well-defined projects that are realistically achievable within a two-year period and with limited funding. The announcement emphasizes the kinds of work that fit the R03 model: pilot and feasibility studies that test whether a larger project is workable, secondary analyses of existing datasets, small and self-contained research efforts that answer a targeted question, and the development of research methods or new research technologies. This structure makes the program especially relevant for teams that want to launch an international collaboration, generate preliminary data, validate an approach in a new context, or leverage existing international data resources to answer timely questions in addiction science.
The FOA highlights example priority topics that were particularly relevant in FY2015 to illustrate the types of areas NIDA was encouraging. These include research at the intersection of HIV/AIDS and drug abuse, such as how substance use relates to HIV prevention and treatment outcomes, and how prevention or treatment strategies can be strengthened in populations affected by both conditions. Another emphasized area is nicotine and tobacco use, especially research focused on initiation and treatment among vulnerable groups such as children, adolescents, pregnant women, and individuals with co-occurring disorders. The announcement also points to interest in the neuroscience of marijuana and cannabinoids, as well as research on how changes in marijuana laws and policies influence marijuana use and related public health impacts. While these are examples tied to a specific period, the broader message is that NIDA is looking for international collaborations that address pressing addiction-related scientific and public health questions and that benefit from international settings in a way that meaningfully strengthens the research.
Eligibility for this opportunity is broad and includes many types of U.S.-based organizations and governmental entities, such as state, county, city, township, special district governments, independent school districts, public and private institutions of higher education, and nonprofit organizations (including both 501(c)(3) and certain non-501(c)(3) nonprofits). It also allows for participation by for-profit organizations (other than small businesses) and small businesses, as well as public housing authorities and tribal entities. Importantly for an international collaboration program, non-U.S. entities (foreign organizations) are listed as eligible applicants, along with regional organizations, U.S. territories or possessions, and a range of mission-serving institutions such as HBCUs, Hispanic-serving institutions, AANAPISIs, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations where applicable. The announcement notes there is no cost sharing or matching requirement.
Administratively, the opportunity was posted on March 17, 2015, with an original and current closing date of May 7, 2018, and an archive date of June 7, 2018, meaning it is not an active, open competition today but remains as a reference point for the program’s goals and structure during that period. The associated CFDA number is 93.279 (Drug Abuse and Addiction Research Programs), and the sponsoring agency is NIH through NIDA. For full official details, applicants were directed to the NIH Grants Guide page for PA 15-141, with NIH Office of Extramural Research webmaster contacts provided for access or technical issues.
FAQs: International Research Collaboration on Drug Abuse and Addiction Research (R03) - PA 15-141
What is the International Research Collaboration on Drug Abuse and Addiction Research (R03) opportunity (PA 15-141)?
PA 15-141 is a National Institutes of Health (NIH) funding opportunity announcement for short, focused research projects in drug abuse and addiction that rely on international partnerships. It uses the NIH R03 grant mechanism and is intended to support discrete, well-defined projects that can be completed within a two-year period with limited funding.
Which NIH institute sponsors this program?
The sponsoring agency is NIH through the National Institute on Drug Abuse (NIDA).
What is the main purpose of this funding opportunity?
The central purpose is to support international collaborative studies that can advance drug abuse and addiction science more quickly by leveraging resources, advantages, or access that are difficult or impossible to obtain within the United States.
What makes a project a good fit for this international collaboration program?
A strong fit is a project where the international setting or partnership materially strengthens the work. Examples of international advantages described in the announcement include access to unique expertise, specialized facilities, distinctive datasets, particular environmental conditions, or specific populations and settings in other countries.
What kinds of research activities are encouraged under the R03 mechanism?
The announcement highlights several types of work that match the R03 model: pilot and feasibility studies, secondary analyses of existing datasets, small self-contained projects addressing a targeted research question, and the development of research methods or new research technologies.
How long is the expected project period for an R03 under this opportunity?
The R03 mechanism referenced in the announcement is designed for projects that are realistically achievable within a two-year period.
Is this opportunity intended for large, multi-year research programs?
No. The opportunity is framed around the NIH R03 mechanism, which is intended for discrete, well-defined projects with limited funding and a two-year scope rather than large or long-term research programs.
Does the project need to align with NIDA's mission?
Yes. Applications are expected to align with NIDA's mission. The announcement also notes that, when practical, projects should connect with NIDA international scientific priority areas, acknowledging that those priorities may shift over time.
What example scientific topics were highlighted in the announcement?
The FOA provided FY2015-era examples to illustrate the types of areas NIDA was encouraging. These examples included: research at the intersection of HIV/AIDS and drug abuse; nicotine and tobacco use research (including initiation and treatment), particularly among vulnerable groups; and neuroscience of marijuana and cannabinoids, including research on how marijuana laws and policies influence use and related public health impacts.
Are the listed topic areas mandatory requirements for an application?
The announcement presents them as example priority topics that were particularly relevant in FY2015 to illustrate encouraged areas. It also emphasizes the broader objective of supporting international collaborations that address pressing addiction-related scientific and public health questions and benefit meaningfully from international settings.
What does the FOA say about HIV/AIDS-related research in this context?
It identifies interest in research at the intersection of HIV/AIDS and drug abuse, including how substance use relates to HIV prevention and treatment outcomes, and how prevention or treatment strategies can be strengthened in populations affected by both conditions.
What does the FOA say about nicotine and tobacco research?
It highlights interest in nicotine and tobacco use research, including initiation and treatment, with emphasis on vulnerable groups such as children, adolescents, pregnant women, and individuals with co-occurring disorders.
What does the FOA say about marijuana-related research?
It points to interest in the neuroscience of marijuana and cannabinoids, as well as research on how changes in marijuana laws and policies influence marijuana use and related public health impacts.
Who is eligible to apply for this funding opportunity?
Eligibility is broad. The announcement lists many types of eligible applicants, including U.S.-based governmental entities and organizations (such as state, county, city, township, special district governments, and independent school districts), public and private institutions of higher education, nonprofit organizations (including 501(c)(3) and certain non-501(c)(3) nonprofits), for-profit organizations (other than small businesses), small businesses, public housing authorities, and tribal entities.
Are non-U.S. (foreign) organizations eligible to apply?
Yes. Non-U.S. entities (foreign organizations) are listed as eligible applicants. The announcement also mentions regional organizations, U.S. territories or possessions, and various mission-serving institutions.
Which mission-serving or special categories of institutions are mentioned as eligible?
The announcement includes examples such as HBCUs, Hispanic-serving institutions, AANAPISIs, tribally controlled colleges and universities, Alaska Native and Native Hawaiian serving institutions, and faith-based or community-based organizations where applicable.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
What is the CFDA number associated with this opportunity?
The associated CFDA number is 93.279, titled Drug Abuse and Addiction Research Programs.
When was this funding opportunity posted, and is it still open?
It was posted on March 17, 2015. The original and current closing date listed is May 7, 2018, and the archive date is June 7, 2018. Based on these dates, it is not an active, open competition today and remains available as a reference for the program's goals and structure during that period.
Where were applicants directed to find the official details for PA 15-141?
Applicants were directed to the NIH Grants Guide page for PA 15-141 for full official details.
Who was listed for access or technical issues related to the announcement?
The announcement notes that NIH Office of Extramural Research webmaster contacts were provided for access or technical issues.
What is the key distinguishing feature of projects supported by this FOA?
The distinguishing feature is that the science depends on partnerships and advantages outside the United States, using international resources or settings to strengthen the research in ways that would be difficult or impossible to replicate domestically.
How might this opportunity be used by teams starting a new collaboration?
The structure is especially relevant for teams seeking to launch an international collaboration, generate preliminary data, validate an approach in a new context, or leverage existing international data resources to answer targeted questions in addiction science.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R01)
Previous opportunity: Cooperative Ecosystem Studies Unit, Californian CESU
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 15 141
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 15 141) also looked into and applied for these:
| Funding Opportunity |
|---|
| International Research Collaboration on Drug Abuse and Addiction Research (R01) Apply for PA 15 142 Funding Number: PA 15 142 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| International Research Collaboration on Drug Abuse and Addiction Research (R21) Apply for PA 15 143 Funding Number: PA 15 143 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Limited Competition Revisions to Add Phase 2 Clinical Trials Program to Experimental Therapeutics Clinical Trials Network (ETCTN)(UM1) Apply for RFA CA 15 501 Funding Number: RFA CA 15 501 Agency: National Institutes of Health Category: Education Health Funding Amount: $560,000 |
| Cancer Research Education Grants Program Research Experiences (R25) Apply for PAR 15 152 Funding Number: PAR 15 152 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Research Education Grants Program Courses for Skills Development (R25) Apply for PAR 15 151 Funding Number: PAR 15 151 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Cancer Research Education Grants Program Curriculum or Methods Development (R25) Apply for PAR 15 150 Funding Number: PAR 15 150 Agency: National Institutes of Health Category: Education Health Funding Amount: $100,000 |
| Administrative Supplements to Promote Cancer Prevention and Control Research in Low and Middle Income Countries (Admin Supp) Apply for PAR 15 155 Funding Number: PAR 15 155 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research Answers to NCIs Provocative Questions (R21) Apply for RFA CA 15 009 Funding Number: RFA CA 15 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Research Answers to NCIs Provocative Questions (R01) Apply for RFA CA 15 008 Funding Number: RFA CA 15 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Regional Medical Libraries for the National Network of Libraries of Medicine (UG4) Apply for RFA LM 15 003 Funding Number: RFA LM 15 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34) Apply for PA 15 177 Funding Number: PA 15 177 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Abuse (R34) Apply for PA 15 250 Funding Number: PA 15 250 Agency: National Institutes of Health Category: Education Health Funding Amount: $225,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R01) Apply for PA 15 251 Funding Number: PA 15 251 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R03) Apply for PA 15 252 Funding Number: PA 15 252 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Health Services and Economic Research on the Prevention and Treatment of Drug, Alcohol, and Tobacco Abuse (R21) Apply for PA 15 253 Funding Number: PA 15 253 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Development of Measures of Fatigability in Older Adults (R21) Apply for RFA AG 16 013 Funding Number: RFA AG 16 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Provocative Questions in Cancer with an Underlying HIV Infection (R21) Apply for RFA CA 15 013 Funding Number: RFA CA 15 013 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Provocative Questions (PQ) Initiative Cancer with an Underlying HIV Infection (R01) Apply for RFA CA 15 012 Funding Number: RFA CA 15 012 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Clinical and Translational Science Award (CTSA) Network Recruitment Innovation Centers (RICs)(U24) Apply for RFA TR 15 004 Funding Number: RFA TR 15 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Assay Validation For High Quality Markers For NCI Supported Clinical Trials (Admin Supp) Apply for PA 15 264 Funding Number: PA 15 264 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 15 141", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.